India Diabetes: Curbing the surge of diabetes in India needs collaborative effort: Novo Nordisk CEO

Lars Fruergaard Jorgensen, global CEO, Novo Nordisk; image credit: Company


Lars Fruergaard Jørgensen, the CEO of Novo Nordisk, the world’s largest producer of insulins, shares his thoughts on how to arrest the growing numbers of diabetes patients; the company’s blockbuster weight-loss drug Wegovy; regulating medicine prices; and more.

For Lars Fruergaard Jørgensen, CEO, Novo Nordisk, the world’s largest producer of insulins, India is a crucial market, amid the worrying uptrend in the reported number of cases of diabetics and pre-diabetics. Besides making medical treatment available and imparting training to nurses, he says, it is important that people in big cities change the way they live. From meals to giving up a sedentary lifestyle, everything needs to be reviewed

  • SAVE

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

  • ​Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-​

Leave a Reply

Your email address will not be published. Required fields are marked *